These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26663426)

  • 1. Cardiovascular risk assessment in oncological clinical trials: is there a role for centralized events adjudication?
    Vaduganathan M; Prasad V
    Eur J Heart Fail; 2016 Feb; 18(2):128-32. PubMed ID: 26663426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drugs cardiotoxicity].
    Capilla E; Poyet R; Brocq FX; Pons F; Kerebel S; Jego C; Laurent P; Cellarier GR
    Presse Med; 2015 Oct; 44(10):995-1002. PubMed ID: 26153088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality assessment and treatment of chemotherapy-induced cardiotoxicity.
    Storozynsky E
    Future Cardiol; 2015 Jul; 11(4):421-4. PubMed ID: 26238563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiotoxicity of chemotherapy. An increasing problem in oncology and cardiology].
    Stiefelhagen P
    Med Monatsschr Pharm; 2011 Mar; 34(3):96-9. PubMed ID: 21736014
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy-related cardiotoxicity.
    Aggarwal S; Kamboj J; Arora R
    Ther Adv Cardiovasc Dis; 2013 Apr; 7(2):87-98. PubMed ID: 23487044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Representation of Patients With Cardiovascular Disease in Pivotal Cancer Clinical Trials.
    Bonsu J; Charles L; Guha A; Awan F; Woyach J; Yildiz V; Wei L; Jneid H; Addison D
    Circulation; 2019 May; 139(22):2594-2596. PubMed ID: 30882246
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiotoxicity: cisplatin and long-term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Jul; 175(1):201-2. PubMed ID: 24820740
    [No Abstract]   [Full Text] [Related]  

  • 9. Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.
    Zambelli A; Della Porta MG; Eleuteri E; De Giuli L; Catalano O; Tondini C; Riccardi A
    Breast; 2011 Apr; 20(2):176-83. PubMed ID: 21146409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity: anthracyclines and long term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Oct; 176(3):1326-8. PubMed ID: 25129289
    [No Abstract]   [Full Text] [Related]  

  • 11. [I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia].
    ; ; ; ; Kalil Filho R; Hajjar LA; Bacal F; Hoff PM; Diz Mdel P; Galas FR; Fukushima JT; Almeida JP; Nakamura RE; Trielli TR; Bittar CS; Santos MH; Galdeano FG; Auler Júnior JO; Silvestrini AA; Alencar A; Mota AC; Gusmão CA; Almeida DR; Simões CM; Bocchi EA; Lima EM; Fernandes F; Silveira FS; Vilas-Boas F; Beck da Silva Neto L; Rohde LE; Montera MW; Barbosa M; Mano MS; Riechelmann RS; Arai RJ; Martins SM; Ferreira SM; Santos V
    Arq Bras Cardiol; 2011; 96(2 Suppl 1):1-52. PubMed ID: 21468528
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiotoxicity and cancer therapy.
    Vasiliadis I; Kolovou G; Mikhailidis DP
    Angiology; 2014 May; 65(5):369-71. PubMed ID: 23921503
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular complications of chemotherapy].
    Tovena DM; Inzoli A; Donato G; Gazzaniga P; Bianchessi C
    G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):165S-170S. PubMed ID: 23096398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-Specific Cardiovascular Risks of Cancer and Its Therapies.
    Wilcox NS; Rotz SJ; Mullen M; Song EJ; Ky Hamilton B; Moslehi J; Armenian SH; Wu JC; Rhee JW; Ky B
    Circ Res; 2022 Feb; 130(4):632-651. PubMed ID: 35175846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity: trastuzumab and cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Dec; 177(2):554-6. PubMed ID: 25205483
    [No Abstract]   [Full Text] [Related]  

  • 16. Tyrosine kinase-inhibitors and heart failure risk.
    Das M
    Lancet Oncol; 2017 Jun; 18(6):e302. PubMed ID: 28438474
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy Agents With Known Cardiovascular Side Effects and Their Anesthetic Implications.
    Oprea AD; Russell RR; Russell KS; Abu-Khalaf M
    J Cardiothorac Vasc Anesth; 2017 Dec; 31(6):2206-2226. PubMed ID: 26952170
    [No Abstract]   [Full Text] [Related]  

  • 18. SEOM clinical guidelines on cardiovascular toxicity (2018).
    Virizuela JA; García AM; de Las Peñas R; Santaballa A; Andrés R; Beato C; de la Cruz S; Gavilá J; González-Santiago S; Fernández TL
    Clin Transl Oncol; 2019 Jan; 21(1):94-105. PubMed ID: 30627982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioncology: state of the heart.
    Todaro MC; Oreto L; Qamar R; Paterick TE; Carerj S; Khandheria BK
    Int J Cardiol; 2013 Sep; 168(2):680-7. PubMed ID: 23639459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular toxicity caused by cancer treatment: strategies for early detection.
    Altena R; Perik PJ; van Veldhuisen DJ; de Vries EG; Gietema JA
    Lancet Oncol; 2009 Apr; 10(4):391-9. PubMed ID: 19341970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.